Last updated: June 1, 2026
Sponsor: Georgetown University
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
Community peer coaching
PeACE
Clinical Study ID
NCT04248257
STUDY00001007
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- There are two targets for recruitment with different eligibility criteria.
Index carriers:
- Men or women aged 18 or older with BRCA mutations with or without 2nd-tier multiplexpanel genetic testing. Index carriers will have received testing.
YARs:
- Female 1st-, 2nd- or 3rd-degree biological relatives of index carriers aged 21-30.
Exclusion
Exclusion Criteria:
- Must be able to speak English or Spanish and provide informed consent
Study Design
Total Participants: 320
Treatment Group(s): 2
Primary Treatment: Community peer coaching
Phase:
Study Start date:
July 15, 2020
Estimated Completion Date:
April 17, 2026
Study Description
Connect with a study center
Georgetown University
Washington D.C., District of Columbia 20007
United StatesSite Not Available
Dana Farber Cancer Center
Boston, Massachusetts 02215
United StatesSite Not Available
Hackensack University Medical Center
Hackensack, New Jersey 07061
United StatesSite Not Available
Memorial Sloan Kettering Cancer Center
New York, New York 10022
United StatesSite Not Available
University of Texas Southwestern Medical Center
Dallas, Texas 75390-9020
United StatesSite Not Available
University of Washington
Seattle, Washington 98109
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.